| Product Code: ETC319644 | Publication Date: Aug 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Colistin Market was estimated at USD 1191 Million in 2025 and is projected to reach USD 1707 Million by 2032, growing at a CAGR of 5.3% from 2026 to 2032. This robust growth trajectory is fueled by an escalating prevalence of multidrug-resistant infections in both human and veterinary healthcare settings. The increasing recognition of colistin as a last-resort antibiotic, especially for severe gram-negative bacterial infections, underscores its critical role in modern therapeutics.
This graph highlights how the India Colistin Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.2% | decrease in healthcare investments |
| 2022 | 9.1% | rise in livestock farming activities |
| 2023 | 7.5% | increased demand for antibiotics |
| 2024 | 7.3% | expansion in pharmaceutical manufacturing |
| 2025 | 7.7% | growing awareness of animal health |
| 2026 | 7.6% | enhancements in veterinary services |
| 2027 | 6.6% | higher investments in research |
| 2028 | 6.4% | improvement in agricultural practices |
| 2029 | 6.2% | expansion of distribution networks |
| 2030 | 6.4% | increased collaboration with stakeholders |
| 2031 | 6.6% | growth in export opportunities |
| 2032 | 6.0% | growing downstream application demand |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
The India colistin market is on an upward trend, driven by an urgent need for effective antibiotics in the face of rising antimicrobial resistance. Healthcare professionals are increasingly relying on colistin to combat infections, particularly in hospital environments where drug-resistant pathogens pose significant challenges.
Furthermore, the veterinary sector is also witnessing a surge in colistin usage due to the expanding poultry and livestock industries. This growing demand highlights both the therapeutic necessity and the potential risks associated with the antibiotics use, emphasizing the need for careful management to mitigate resistance development.
Despite the promising growth, the India colistin market faces substantial restraints primarily related to the emergence of colistin-resistant bacterial strains. The global health community is increasingly alarmed at the implications of over-reliance on colistin, which may lead to reduced effectiveness of this crucial antibiotic. Furthermore, regulatory pressures aimed at enforcing stricter antibiotic stewardship can impact the overall demand dynamics. The balancing act between availability and responsible usage remains critical for stakeholders in the market.
Several trends are emerging within the India colistin market, notably the increased focus on antibiotic stewardship programs and the promotion of alternative therapies. Healthcare institutions are prioritizing the implementation of guidelines that encourage judicious colistin use. Additionally, ongoing research aims to discover novel antibiotics or adjuvant therapies to complement colistin, thus addressing the urgent need to counteract resistance.
Investment opportunities abound in the India colistin market, particularly in the realm of research and development. Companies are encouraged to innovate and explore alternative treatments and dosage forms. Furthermore, initiatives aimed at enhancing public awareness about antibiotic resistance offer avenues for educational campaigns and responsible use strategies, potentially fostering a more sustainable market ecosystem.
The Indian government has been actively involved in addressing antibiotic resistance through various initiatives and policies. These include funding for research projects targeting new antibiotic development and public health campaigns aimed at educating healthcare providers and the public about the risks of antibiotic misuse. Additionally, regulatory bodies are increasingly scrutinizing the veterinary use of colistin, pushing for guidelines that promote responsible application.
Looking forward to 2026-2032, the India colistin market is poised for a period of evolution characterized by heightened scrutiny and innovation. Stakeholders will likely emphasize research into alternatives and combination therapies to combat the tide of antimicrobial resistance. As healthcare policies evolve to promote sustainable antibiotic use, the market will need to adapt, potentially leading to a more balanced approach to colistin application across both human and veterinary sectors.
Recent developments in the India colistin market highlight a growing emphasis on responsible use and stewardship initiatives. Stakeholders are increasingly investing in educational programs aimed at healthcare professionals and the public, reinforcing the importance of judicious colistin application. Moreover, collaborations between government entities and research organizations are gaining traction, aiming to address antibiotic resistance through innovative strategies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Colistin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Colistin Market Revenues & Volume, 2022 & 2032F |
3.3 India Colistin Market - Industry Life Cycle |
3.4 India Colistin Market - Porter's Five Forces |
3.5 India Colistin Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 India Colistin Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 India Colistin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multidrug-resistant bacterial infections in India |
4.2.2 Rise in hospital-acquired infections and nosocomial infections |
4.2.3 Growing awareness about the effectiveness of colistin in treating severe bacterial infections |
4.3 Market Restraints |
4.3.1 Concerns over the development of colistin resistance in bacteria |
4.3.2 Stringent regulations on the use of antibiotics in livestock and poultry farming |
4.3.3 High cost associated with colistin treatment |
5 India Colistin Market Trends |
6 India Colistin Market, By Types |
6.1 India Colistin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Colistin Market Revenues & Volume, By Product Type, 2022-2032F |
6.1.3 India Colistin Market Revenues & Volume, By API, 2022-2032F |
6.1.4 India Colistin Market Revenues & Volume, By Premix, 2022-2032F |
6.1.5 India Colistin Market Revenues & Volume, By Others, 2022-2032F |
6.2 India Colistin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Colistin Market Revenues & Volume, By Pig, 2022-2032F |
6.2.3 India Colistin Market Revenues & Volume, By Chicken, 2022-2032F |
6.2.4 India Colistin Market Revenues & Volume, By Other, 2022-2032F |
7 India Colistin Market Import-Export Trade Statistics |
7.1 India Colistin Market Export to Major Countries |
7.2 India Colistin Market Imports from Major Countries |
8 India Colistin Market Key Performance Indicators |
8.1 Percentage increase in the number of reported cases of multidrug-resistant bacterial infections in India |
8.2 Adoption rate of colistin in hospitals and healthcare facilities |
8.3 Research and development investments in alternative treatments to colistin for bacterial infections |
9 India Colistin Market - Opportunity Assessment |
9.1 India Colistin Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 India Colistin Market Opportunity Assessment, By Application, 2022 & 2032F |
10 India Colistin Market - Competitive Landscape |
10.1 India Colistin Market Revenue Share, By Companies, 2025 |
10.2 India Colistin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here